Drug Type CAR-M |
Synonyms- |
Target- |
Mechanism Immunologic cytotoxicity, Macrophage replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Shoreline Biosciences, Inc.Startup |
Active Organization Shoreline Biosciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | US | Shoreline Biosciences, Inc.Startup | - |